More than 160 U.S. lawmakers have urged the Trump administration to abandon a newly announced pilot program that would allow ...

The 340B program presents covered entities with very important financial support to assist with the extension of care to the most vulnerable populations. However, the program is under scrutiny ...

The American Hospital Association is asking the Federal Trade Commission and the Department of Justice to get involved in the ...

The somewhat obscure federal program designed to reduce drug prices for health providers is getting scrutiny from lawmakers this year.

The hospital lobby wants the Trump administration to investigate Johnson & Johnson, Eli Lilly, Sanofi, Novartis and Bristol ...

The American Hospital Association is calling on federal regulators to launch an antitrust investigation into its claims of drug manufacturers’ actions regarding 340B rebate models. In a letter sent to ...

AHA letter to the Federal Trade Commission and Department of Justice regarding anticompetitive activity by drug companies with respect to 340B “rebate models.” ...

The 340B drug pricing program is complicated. A clinic leader and a hospital said that’s making it easy for there to be misunderstandings about if the savings are being passed onto the patient.

The 340B Drug Pricing Program (“340B Program”) is a federal drug discount program that Congress passed into law in 1992. The 340B Program requires drug manufacturers to provide drugs at discounted ...

A growing drug program is helping hospitals instead of the uninsured, kids and elderly it was meant to help, says Brian Nyquist.

INDIANAPOLIS (Indiana Capital Chronicle) — A somewhat obscure federal program designed to reduce drug prices for health providers is getting scrutiny from lawmakers this year, with many ...

The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several ...